Abstract
Calcium is a ubiquitous second messenger and is involved in virtually all cellular functions. Cellular events being regulated by calcium include gene transcription, metabolism, proliferation and apoptosis. Cancer growth is based on increased proliferation, decreased differentiation and decreased apoptosis. Therefore, the intracellular Ca2+-homeostasis has become one of the focuses in current cancer research. Elevation of the cytoplasmic Ca2+-concentration can result from Ca2+-influx from the extracellular space or from Ca2+-release from intracellular stores. The main intracellular Ca2+-store is the endoplasmic reticulum (ER). The Ca2+-content of the ER is maintained by trans-membrane proteins involving the sarco/endoplasmic reticulum Ca2+-ATPase and the inositol-1,4,5-phosphat receptor. In this review, we summarize the current knowledge of the ER and its trans-membrane proteins as regulating structures of the intracellular Ca2+- homeostasis, what changes occur in malignant cells and how this promotes cancer. We further review possible pharmacological intervention and show future perspectives of the intracellular Ca2+-homeostasis as an anti-cancer target.
Keywords: Cancer, endoplasmic reticulum, calcium, SERCA, IP3R
Anti-Cancer Agents in Medicinal Chemistry
Title: Regulation of the Endoplasmic Reticulum Ca2+-Store in Cancer
Volume: 8 Issue: 7
Author(s): A. Bergner and R. M. Huber
Affiliation:
Keywords: Cancer, endoplasmic reticulum, calcium, SERCA, IP3R
Abstract: Calcium is a ubiquitous second messenger and is involved in virtually all cellular functions. Cellular events being regulated by calcium include gene transcription, metabolism, proliferation and apoptosis. Cancer growth is based on increased proliferation, decreased differentiation and decreased apoptosis. Therefore, the intracellular Ca2+-homeostasis has become one of the focuses in current cancer research. Elevation of the cytoplasmic Ca2+-concentration can result from Ca2+-influx from the extracellular space or from Ca2+-release from intracellular stores. The main intracellular Ca2+-store is the endoplasmic reticulum (ER). The Ca2+-content of the ER is maintained by trans-membrane proteins involving the sarco/endoplasmic reticulum Ca2+-ATPase and the inositol-1,4,5-phosphat receptor. In this review, we summarize the current knowledge of the ER and its trans-membrane proteins as regulating structures of the intracellular Ca2+- homeostasis, what changes occur in malignant cells and how this promotes cancer. We further review possible pharmacological intervention and show future perspectives of the intracellular Ca2+-homeostasis as an anti-cancer target.
Export Options
About this article
Cite this article as:
Bergner A. and Huber M. R., Regulation of the Endoplasmic Reticulum Ca2+-Store in Cancer, Anti-Cancer Agents in Medicinal Chemistry 2008; 8 (7) . https://dx.doi.org/10.2174/187152008785914734
DOI https://dx.doi.org/10.2174/187152008785914734 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Metabolism and Pharmacological Mechanisms of Active Ingredients in <i>Erigeron breviscapus</i>
Current Drug Metabolism microRNAs as Anti-Cancer Therapy
Current Pharmaceutical Design Nociceptin / Orphanin FQ (NOP) Receptors as Novel Potential Target in the Treatment of Gastrointestinal Diseases
Current Drug Targets Targeted Alpha Therapy with 213Bi
Current Radiopharmaceuticals Application of Genetic Polymorphisms in DNA Repair in the Prediction of Cancer Susceptibility and Clinical Outcome
Current Pharmacogenomics Regulation of Multidrug Resistance by Pro-Inflammatory Cytokines
Current Cancer Drug Targets Emerging Role of Stromal Fibroblasts in Epithelial Cancer
Current Signal Transduction Therapy Potential Natural Dual Agonist PPARα/γ-induced Antidiabetic and Antidyslipidemic Properties of Safrole-Free Nutmeg Seed (Myristica fragrans Houtt) Extract
The Natural Products Journal Chalcones in Cancer: Understanding their Role in Terms of QSAR
Current Medicinal Chemistry Conditionally Replicating Adenoviruses for Cancer Treatment
Current Cancer Drug Targets The Anticancer Properties of Dietary Polyphenols and its Relation with Apoptosis
Current Pharmaceutical Design GH-Inhibitory Activity of Novel Somatostatin Agonists: Potential Applications in Acromegaly
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Withdrawal Notice: Characterization of Glyoxal Modified LDL: Role in the Generation of Circulating Autoantibodies in Type 2 Diabetes Mellitus and Coronary Artery Disease
Current Drug Targets Targeting Host Cell Proteases to Prevent SARS-CoV-2 Invasion
Current Drug Targets Mouse Mutants of Relaxin, Insulin-Like 3 Peptide and their Receptors
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Cordycepin Suppresses Integrin/FAK Signaling and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry The Emerging Role of Coenzyme Q-10 in Aging, Neurodegeneration, Cardiovascular Disease, Cancer and Diabetes Mellitus
Current Neurovascular Research The Use of the Bone Seeking Radiopharmaceutical 153-Samarium-EDTMP as an Adjuvant Treatment for Osteosarcoma: A Review
Current Medical Imaging A Transporter Gene (Sodium Iodide Symporter) for Dual Purposes in Gene Therapy: Imaging and Therapy
Current Gene Therapy Expression and Single Nucleotide Polymorphism of Poly (ADPRibose) Polymerase-1 in Gastrointestinal Tumours: Clinical Involvement
Current Medicinal Chemistry